erlotinib has been researched along with pha 680632 in 1 studies
| Studies (erlotinib) | Trials (erlotinib) | Recent Studies (post-2010) (erlotinib) | Studies (pha 680632) | Trials (pha 680632) | Recent Studies (post-2010) (pha 680632) |
|---|---|---|---|---|---|
| 221 | 0 | 180 | 20 | 0 | 14 |
| Protein | Taxonomy | erlotinib (IC50) | pha 680632 (IC50) |
|---|---|---|---|
| Aurora kinase A | Homo sapiens (human) | 0.027 | |
| LIM domain kinase 1 | Homo sapiens (human) | 0.4914 | |
| LIM domain kinase 2 | Homo sapiens (human) | 7.9433 | |
| Aurora kinase B | Homo sapiens (human) | 0.108 | |
| Aurora kinase C | Homo sapiens (human) | 0.12 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
1 other study(ies) available for erlotinib and pha 680632
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |